Oblique Therapeutics Company

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.
Technology: Anti-infective Drugs
Industry: PharmTech
Headquarters: G˜РЄ њРЎteborg, Vastra Gotaland, Sweden
Founded Date: 2015
Employees Number: 1-10
Total Funding: €130K
Estimated Revenue: Less than $1M
Last Funding Type: Pre-Seed
Visit Website
info@obliquet.com
Register and Claim Ownership